Meiko Trans Co., Ltd. (XNGO:9357)

Elevation Oncology Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	61,154	47,248	47,778	35,288	34,275	34,394
Market Cap Growth	24.28%	-1.11%	35.39%	2.96%	-0.35%	7.85%
Enterprise Value	36,806	29,730	33,609	29,147	27,825	25,925
Last Close Price	2045.00	1580.00	1553.58	1119.19	1055.82	1030.67
PE Ratio	10.55	8.78	10.52	7.60	7.41	7.97
PS Ratio	0.74	0.58	0.62	0.42	0.42	0.51
PB Ratio	0.48	0.37	0.39	0.32	0.33	0.35
P/TBV Ratio	0.49	0.39	0.41	0.34	0.35	0.37
P/FCF Ratio	-	7.31	5.70	22.11	-	21.48
P/OCF Ratio	-	5.46	4.77	3.55	7.31	5.74
EV/Sales Ratio	0.45	0.37	0.43	0.35	0.34	0.39
EV/EBITDA Ratio	3.49	3.00	3.81	3.03	2.93	4.12
EV/EBIT Ratio	5.36	4.74	6.38	4.67	4.31	7.25
EV/FCF Ratio	-	4.60	4.01	18.26	-	16.19
Debt / Equity Ratio	0.04	0.05	0.06	0.10	0.07	0.07
Debt / EBITDA Ratio	0.54	0.60	0.76	1.15	0.75	1.04
Debt / FCF Ratio	-	0.92	0.80	6.91	-	4.07
Asset Turnover	0.54	0.53	0.54	0.62	0.64	0.56
Quick Ratio	4.50	3.93	3.48	2.44	2.02	2.10
Current Ratio	4.85	4.23	3.79	2.72	2.30	2.26
Return on Equity (ROE)	4.94%	4.66%	4.17%	4.71%	4.88%	4.72%
Return on Assets (ROA)	2.72%	2.57%	2.27%	2.88%	3.17%	1.88%
Return on Capital (ROIC)	3.16%	3.01%	2.65%	3.40%	3.77%	2.21%
Return on Capital Employed (ROCE)	4.60%	4.40%	3.80%	5.00%	5.60%	3.30%
Earnings Yield	9.48%	11.39%	9.50%	13.15%	13.49%	12.55%
FCF Yield	-	13.69%	17.54%	4.52%	-2.77%	4.66%
Dividend Yield	2.32%	2.91%	2.45%	3.04%	2.75%	2.14%
Payout Ratio	-	23.89%	22.99%	24.09%	14.19%	15.19%
Buyback Yield / Dilution	-0.13%	-0.14%	-0.15%	0.00%	-	-
Total Shareholder Return	2.20%	2.77%	2.30%	3.04%	2.75%	2.14%

Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.